Physician profile
Arthur H Katz
NPI 1124035720
$11,832.44
in general payments reported to CMS, 2019-2025
22 companies · $1,929 in 2025
The $1,929 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $4,466 · 2021: $1,635 · 2022: $1,407 · 2023: $1,176 · 2024: $467 · 2025: $1,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,332 · Travel and Lodging: $1,240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,332.03 |
| Travel and Lodging | $1,240.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,242.36 | 2020 | |
| Atricure, INC. | $2,303.18 | 2020-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Medtronic, INC. | $1,301.19 | 2021-2025 | Avalus, Vitalflow Console |
| Cvrx, INC. | $1,123.25 | 2024-2025 | Barostim Neo System |
| Abiomed | $820.61 | 2019-2024 | Impella |
| Edwards Lifesciences Corporation | $714.71 | 2019-2025 | Sapien 3 Ultra Resilia |
| Getinge USA Sales, LLC | $457.33 | 2019-2025 | Vasoview Hemopro 2, Acrobat-I Stabilizer |
| Biomerieux INC | $312.44 | 2022 | |
| Lsi Solutions INC | $197.76 | 2022-2025 | Cor-Knot |
| Medtronic Vascular, INC. | $190.86 | 2019 | |
| Abbott Laboratories | $188.01 | 2020-2023 | Epic |
| La Jolla Pharmaceutical Company | $149.87 | 2020-2021 | |
| Penumbra, INC. | $140.00 | 2023 | Smart Coil |
| Bolton Medical INC | $137.74 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $124.99 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $121.84 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $102.24 | 2022 | |
| Clearflow INC. | $67.39 | 2025 | Pleuraflow System With Flowglide |
| Ethicon US, LLC | $49.93 | 2021 | |
| Artivion, INC. | $48.10 | 2021 | |
| Terumo Cardiovascular Systems Corporation | $24.79 | 2024 | Terumo Advanced Perfusion System 1 |
| Janssen Pharmaceuticals, INC | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.